Author:
Ochoa Maria,Jurencak Roman,Smit Kevin,Carsen Sasha,Sawyer Sarah L.,Robinson Marie-Eve,Khatchadourian Karine,Cheng Hooi Peng,Pagé Marika,Werier Joel,Ward Leanne Marie
Subject
Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism
Reference14 articles.
1. Differential response of idiopathic sporadic tumoral calcinosis to bisphosphonates;Balachandran;Indian J. Endocrinol. Metab. [Internet],2014
2. An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia;Benet-Pagès;Hum. Mol. Genet. [Internet],2005
3. Hyperphosphatemic tumoral calcinosis: pathogenesis, clinical presentation, and challenges in management;Boyce;Front. Endocrinol. (Lausanne) [Internet],2020
4. Hyperphosphatemic familial tumoral calcinosis with Galnt3 mutation: transient response to anti-interleukin-1 treatments;Dauchez;JBMR Plus [Internet],2019
5. The successful treatment of deep soft-tissue calcifications with topical sodium thiosulphate and acetazolamide in a boy with hyperphosphatemic familial tumoral calcinosis due to a novel mutation in FGF23;Doneray;J. Clin. Res. Pediatr. Endocrinol. [Internet],2021
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献